These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 26175151)
1. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma. Burkhalter RJ; Westfall SD; Liu Y; Stack MS J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151 [TBL] [Abstract][Full Text] [Related]
2. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2. Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501 [TBL] [Abstract][Full Text] [Related]
3. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway. Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697 [TBL] [Abstract][Full Text] [Related]
4. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer. Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316 [TBL] [Abstract][Full Text] [Related]
5. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis. Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511 [TBL] [Abstract][Full Text] [Related]
6. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway. Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518 [TBL] [Abstract][Full Text] [Related]
7. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway. Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068 [TBL] [Abstract][Full Text] [Related]
8. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Zhang Y; Dun Y; Zhou S; Huang XH Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819 [TBL] [Abstract][Full Text] [Related]
9. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway. Hu C; Dong T; Li R; Lu J; Wei X; Liu P Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690 [TBL] [Abstract][Full Text] [Related]
10. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227 [TBL] [Abstract][Full Text] [Related]
11. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis. Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130 [TBL] [Abstract][Full Text] [Related]
12. Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling. Bernaudo S; Salem M; Qi X; Zhou W; Zhang C; Yang W; Rosman D; Deng Z; Ye G; Yang BB; Vanderhyden B; Wu Z; Peng C Oncogene; 2016 Sep; 35(36):4816-27. PubMed ID: 26876206 [TBL] [Abstract][Full Text] [Related]
13. Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3 Lu J; Xu Y; Wei X; Zhao Z; Xue J; Liu P Biomed Res Int; 2016; 2016():6253280. PubMed ID: 28097141 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway. Zhuang XH; Liu Y; Li JL Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688 [TBL] [Abstract][Full Text] [Related]
15. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497 [TBL] [Abstract][Full Text] [Related]
16. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model. Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765 [TBL] [Abstract][Full Text] [Related]
17. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. Yan D; Avtanski D; Saxena NK; Sharma D J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359 [TBL] [Abstract][Full Text] [Related]
18. Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Bitler BG; Nicodemus JP; Li H; Cai Q; Wu H; Hua X; Li T; Birrer MJ; Godwin AK; Cairns P; Zhang R Cancer Res; 2011 Oct; 71(19):6184-94. PubMed ID: 21816908 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway. Wei C; Zhang X; He S; Liu B; Han H; Sun X Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1. Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]